Alsita-M 100 Tablet ER
Marketer
Alkem Laboratories Ltd
Salt Composition
Sitagliptin (100mg) + Metformin (500mg)
Overview Alsita-M 100 Tablet ER
Diabetica Duo 100 Extended-Release tablets combine two agents to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). Diabetica Duo 100 ER may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming the medication with food minimizes gastrointestinal upset. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle significantly impacts glycemic control. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your physician will monitor renal function and blood glucose levels before, during, and after treatment.
Primary Ingredients of Alsita-M 100 Tablet ER
No information provided. Please provide the text you wish to be rewritten.
Uses of Alsita-M 100 Tablet ER
Managing type 2 diabetes
Major Benefits of Alsita-M 100 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alsita-M 100 ER tablets should be administered with a meal.
Common Side effects of Alsita-M 100 Tablet ER:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Alsita-M 100 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alsita-M 100 Extended-Release Tablet should be administered with a meal.
How Alsita-M 100 Tablet ER works:
Alsita-M 100 ER tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Alsita-M 100 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Alsita-M 100mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Alsita-M 100mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Alsita-M 100 Tablet ER cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates the use of Alsita-M 100 Tablet ER. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.
LiverUNSAFE
Extended-release Alsita-M 100mg tablets are contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Alsita-M 100 Tablet ER :
Should you forget a dose of Alsita-M 100 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Alsita-M 100 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





